DDI.SecondLine-TasP Kobus Herbst Joseph Larmarange Jaco Dreyer 2015-11-13 NADA 1.0.0 Concept sheet - Second line treatment TasP Concept Sheet Second line Treatment - TasP SecondlineTasP Africa Centre for Health and Population Studies NADA Agence Nationale de Recherche sur le Sida et les hépatites virales Deutsche Gesellschaft für Internationale Zusammenarbeit MERCK & Co. Inc and Gilead Sciences Wellcome Trust International Initiative for Impact Evaluation Dami Collier 1.0.0 South Africa Twenty Two survey clusters located in Hlabisa sub-district, Umkhanyakude district, of northern KwaZulu-Natal, South Africa. The Hlabisa health sub-district is a rural setting of 1 430 km2 in size, with a population of approximately 220 000 Zuluspeaking people of whom 3.3% are located in a formal urban township (KwaMsane), 19.9% in peri-urban areas and the Treatment as Prevention ANRS 12249 - Overview - 8 - remainder (76.8%) classified as living in a rural area. The rural population lives in scattered homesteads that are not concentrated into villages or compounds (as would be the case in many other parts of Africa). CHE Clinical History and Examination forms 2015 13 ClinicVisits Clinic visits 2960 8 DrugPrescriptions Drug prescriptions 1460 9 PositiveHHMembers Other Positive household members? 125 6 HIVDrugTreatment Antiretroviral drug treatment 2394 17 TestResults Lab Test Results 1393 8 ExitFormDetails Exit Form Details 125 20 Base file Base file 121 24 SCI-CFU Social Science amd Clinical Follow Up 136 15 Individual identifier 121 272 27386 12603.727 7992.42 Cluster Type (arm) 120 Control Intervent Sex 121 FEM MAL Date of birth 121 1915-04-26 1998-06-24 Start date of secondline 121 2000-07-09 2015-05-28 IQ visit date 94 2012-04-30 2015-11-04 Current marital status 94 Engaged Married (monogamous) Married (polygamous) Missing Never been married Widowed Currently in employment 94 No, not employed Yes, full-time Yes, part-time Highest level of education 94 Completed Primary Completed Secondary Deprecated (in IQ1/3, not IQ2) Higher None Some Secondary Some primary Household identifier 84 37 194 10483 3966.524 2488.043 Household visit date 84 2012-04-11 2015-06-17 Has fridge or freezer 84 No Yes Is resident of household 84 No Yes Distance in km to nearest DoH clinic 7 114 1.985 7.542 6.059 2.03 11 .. Distance in km to nearest TasP clinic 7 114 1.171 2.712 1.676 0.631 11 .. Distance in km to N2 (level-1 road) 7 114 0.191 3.698 1.496 1.342 101 .. Assets Score 84 37 -1.539 2.596 -0.0812 0.938 11 .. Assets Score Category 84 high low middle CBC visit date 111 2012-04-03 2015-05-20 Date of HIV Diagnosis 111 1993-06-18 2014-11-09 Currently on ART 111 No Yes Currently on ART - ART provider 111 Hlabisa programme Missing Not applicable Other Currently on ART - ART provider, Hlabisa clinic 111 Hlabisa wards/staff Macabuzela Madwaleni Makhowe Missing Mtubatuba Nkundusi Not applicable Ntondweni Philanjalo (Hlabisa) Somkhele kwaMsane Currently on ART - ART 111 Charls James ((Durban ) GP Doctor Madwaleni Clinic Mandeni Mduku Not applicable Nsingweni Phongola Clinic Individual identifier 2015 272 27386 11983.5 7608.985 Cluster Type (arm) 2000 Control Intervent Sex 2015 FEM MAL Date of birth 2015 1915-04-26 1998-06-24 Start date of secondline 2015 2000-07-09 2015-05-28 Visit identifier 2015 1565 174888 67192.73 43590.624 CHE visit date 2015 2012-06-18 2015-11-13 Current TB treatment (CurrTB) 2015 Missing No Yes Date treatment started (as collected, U means unknown, CurrTB) 49 Date treatment started (CurrTB) 49 1966 1474070400000 1750550400000 1696677355102.04 36561678417.42 10000000000001 .. Drug regimen (CurrTB) 2015 MDR Missing Not applicable Regimen 1 Regimen 2 WHO Stage 2015 Missing Stage 1 Stage 2 Stage 3 Stage 4 TB Site (CurrTB) 2015 EPTB Missing Not applicable Smear+ PTB Smear- PTB Individual identifier 2960 272 27386 11904.288 7801.196 Cluster Type (arm) 2936 Control Intervent Sex 2960 FEM MAL Date of birth 2960 1915-04-26 1998-06-24 Start date of secondline 2960 2000-07-09 2015-05-28 Visit date 2960 2012-04-03 2015-11-25 Location identifier 2960 607 21978 7505.14 5374.617 Visit type 2960 Regular 1 Tracking 10 Clinic, Protocol 10wk 11 Clinic, Protocol 14wk 12 Clinic, Protocol 18wk 13 Clinic, Protocol 22wk 14 Clinic, Protocol 26wk 15 Clinic, Protocol 30wk 16 Clinic, Protocol 34wk 17 Clinic, Protocol 38wk 18 Clinic, Protocol 42wk 19 Clinic, Protocol 46wk 2 Futile Field 20 Clinic, Protocol 50wk 21 Clinic, Protocol 54wk 22 Clinic, Protocol 58wk 23 Clinic, Protocol 62wk 24 Clinic, Protocol 66wk 25 Clinic, Protocol 70wk 26 Clinic, Protocol 74wk 27 Clinic, Protocol 78wk 28 Clinic, Protocol 82wk 29 Clinic, Protocol 86wks 3 Futile Tracking 30 Clinic Protocol 90wk 31 Clinic Protocol 94wk 32 Clinic Protocol 98wk 33 Clinic Protocol 102wk 34 Clinic Protocol 106wk 35 Clinic Protocol 110wk 36 Clinic Protocol 114wk 37 Clinic Protocol 118wk 38 Clinic Protocol 122wk 39 Clinic Protocol 126wk 4 CLO Visit (re Refusals) 40 Clinic Protocol 130wk 41 Clinic Protocol 134wk 42 Clinic Protocol 138wk 43 Clinic Protocol 142wk 44 Clinic Protocol 146wk 45 Clinic Protocol 150wk 46 Clinic Protocol 154wk 47 Clinic Protocol 158wk 48 Clinic Protocol 162wk 49 Clinic Protocol 166wk 5 Clinic, Protocol, Baseline 50 Clinic Protocol 170wk 6 Clinic, Non-protocol 7 Clinic, Protocol 2wk 8 Clinic, Protocol 4wk 9 Clinic, Protocol 6wk 99 Missing Individual identifier 1460 272 27386 11514.99 7874.41 Cluster Type (arm) 1448 Control Intervent Sex 1460 FEM MAL Date of birth 1460 1915-04-26 1998-06-24 Start date of secondline 1460 2000-07-09 2015-05-28 Drug name 1440 Aciclovir Allergex(Chlorphenamine/Piriton) Amethocaine cream Amitriptyline Amlodipine Amoxycillin (Moxypen ) Amphotericin Aqueous cream Aspirin Asthavent (salbutamol) spray Atenolol Azithromycin Benzathine Benzylpenicillin (Peni Lente) Benzyl Benzoate lotion Betadine ointment Bicillin (Penicillin G Benzathine injection)- Biltricide (Praziquantel) Brufen/Ibuprofen(Inza) Buscopan(Hyoscine Butyl bromide) Calamine Lotion Calcium Canesten Vaginal Tab Cefixime Ceftriaxone Chloramex/Chloramphenicol eye ointment Ciprofloxacin (Ciprobay) Cocillana (Cough syrup) Cotrimoxazole Diphenhydramine hydrochloride Doxyclycline Enalapril Epilim, Sodium Valproate Erthromycin FeSO4 Ferrous Fumarate Ferrous sulphate Flucloxacillin (Flupen) Folic Acid (Folate) Gastrolyte (oral rehydration solution) HCT (Hydrochlorothiazide) Haloperidol Hydrocortisone Iliadin spray (Oxymetazoline) Innospore(Clotrimozole) Isoniazid (INH) Loperamide Mebendazole(Wormstop) Medroxyprogesterone (Depo ? provera) Metformin Methy Salicyciate Metoclopramide Metronidazole(Flagyl) Nystatin(Nystacid drops) Panado Paracetamol Penicillin V Petogen (Medroxyprogesterone acetate) Phenytoin Prednisone Pregamol (Ferrous Fumarate + Folic acid) Pyridoxine Selsun shampoo Sorol Spersallerg Sulphasalazine Tranexamic Acid Vitamin A (e.g. BCO) Date prescribed 1440 2012-04-02 2015-11-10 Dose and frequency 1440 0/1 tab dailly 1 T P-O daily 1 TAB DLY 1 TAB DLY 1 Tab DLY 1 Tab dly p.o 1 cap 2 time 1 capsule three times daily 1 daily 1 day 1 dly 1 g -8 hourly 1 g 4 hourly P.R orally 1 g 4-6 hrly orally 1 g 4-6wly orally 1 g 5hrly 1 g 8 hourly 1 g orally 4-6 hourly PRN 1 g p-o prn 1 g p.o prn 1 g p.o. daily 1 g p.o.prn 1 g po prn 1 g prn 1 g shrly 1 g stats 1 g tds / prn 1 g tds prn 1 nocte 1 taab dly 1 tab 1 tab Dly 1 tab daily 1 tab dly 1 tab dly po 1 tab stas 1 tab 12 hrly orally 1 tab 6 hrly orally 1 tab BD 1 tab DLY 1 tab Dly 1 tab QID p-o 1 tab after each loose stool 1 tab after each stool 1 tab bd 1 tab bd po 1 tab daily 1 tab daily 28 1 tab daily orally 1 tab daily p-o 1 tab daily p.o. 1 tab daily po 1 tab db 1 tab dly 1 tab dly nocte 1 tab dly p-o 1 tab dly p.o 1 tab dly p.o. 1 tab dly po 1 tab immediately 1 tab immidiately 1 tab nocte 1 tab oral dldy 1 tab oral dly 1 tab orally rds 1 tab p-o dailly 1 tab p-o daily 1 tab p. o. daily 1 tab p.o daily 1 tab p.o daily 1 tab p.o. Daily 1 tab p.o. daily 1 tab per daily 1 tab po 1 tab po daily 1 tab po nocte 1 tab shrtly 1 tab tds 1 tab tds p-o 1 tab tds po 1 tabafter each loose stool 1 tablet daily 1 tablet daily orally 1 tablets 8hrly PRN for 5days 1 tablets daily orally 1 tablets daily oraly 1 tablets orally daily 1 tablets start then 1 after loose 1 tb dly 1 tds p-o 1 tube apply bd 1 vag tab nocte 1 week p.o. 1% apply 1/1 daily 1/1 dly p.o 1/1 dly po 1/1 nocte orally 1/1 prn 1/1 tab dly 1/2 dly 1/2 start 1/2 tds p.o 10 % cream 20 g apply 10 mg 8-hourly for 10 mg daily 10 mg dly 10 mg dly orally 10 mg on 10 mg p.o prn 10 mg po daily 10 mg po dly 10 ml 8 hrly 10 ml prn 100 mg 12 hourly orally 100 mg 12hrly 100 mg b.d. p.o. 100 mg bd 100 mg bd orally 100 mg daily orally 100 mg dly 100 mg p.o 100 mg po twice 100 mg twice orally 100 orally daily 100mg bd 100mg bd 100mg 12 hourly 100mg 6hrly 100mg bd 100mg bd po 100mg daily 100mg daily p.o 100mg dly 100mg twice 100mg twice daily 100mg twice orally 10mg 10mg dly 10mg dly p.o 10mg 12 hrly 10mg 12hrly 10mg 8 hrly 10mg 8 hrly orally 10mg 8hourly PRN 10mg 8hourly orally PRN 10mg bd 10mg bd p-o 10mg daily 10mg daily for 3days 10mg dly 10mg dly orally 10mg dly p.o 10mg p.o three times 10mg p.o. daily 10mg po dly 10mg prn 10mg tds 10mgdly 10ml 6hrly 10ml 8 hourly 10ml 8 hourly orally 10ml 8 hrly 10ml 8 hrly orally 10ml 8hrly orally 10ml p-o tds 10ml prn 10ml tds 10ml three times daily orally 10mls 6hrly orally 10mls prn 10mls tds p.o 11 taps p.o pm 11/118 hrly p.o 12,5mg 12,5mg daily 12,5mg daily orally 12,5mg dly 12.5 daily p.o. 12.5 g p.o. daily 12.5 mg 12.5 mg daily 12.5 mg daily orally 12.5 mg day 12.5 mg dly 12.5 mg dly orally 12.5 mg oral daily 12.5 mg po daily 12.5 mg po dly 12.5m dly 12.5mg 12.5mg 1 tab dly 12.5mg dly 12.5mg dly orally 12.5mg dly orally 12.5mg daily 12.5mg daly 12.5mg dly 12.5mg dly p.o 12.5mg dly po 12.5mg od 12.5mg oral daily 12.5mg po dly 12.5mgdly 121 5mg dly 150 dly 150 imi 150 mg 150 mg 1 ml 150 mg imi 150 mg imi start 150 mg imi stats 150 mg single dose 1500 mg dly 150mg IMI 150mg daily orally 150mg dly 150mg imi stat 150mg imi stat 19 poprn 1g 4-6hrly orally P.R.N 1g 8hrly 1g p.o prn 1g 4 - 6hrly p.o 1g 4-6 hourly PRN 1g 4-6 hourly orally prn 1g 4-6 hrly orally 1g 4-6hrly 1g 4-6hrly orally 1g 4-6hrly orally 1g 4-6hrly orally P.R.N 1g 4-6hrly orally P.R.N. 1g 8 hourly 1g 8 hrly 1g 8hourly 1g 8hrly 1g 8hrly orally 1g 8hrly po P.R.N 1g 8rhly 1g TDS 1g bd 1g daily 1g dly p.o 1g hrly 1g intramuscular stat 1g oral 6 hourly 1g oral 6hourly 1g p-o prn 1g p-o stat 1g p-o tds 1g p.o prn 1g p.o 8b hourly 1g po 8 hrly 1g prn 1g stat 1g statsimi 1g tds 1g tds / pm 1g tds / prn 1tab 1tab daily 1tab daily orally 1tab dly 1tab twice p.o daily 1tab 3times a day 1tab 4times a day 1tab BD 1tab TDS 1tab after each loose stool 1tab at night 1tab before takin ART /prn 1tab dailly. 1tab daily 1tab daily orally 1tab daily p.o 1tab daily po 1tab dly 1tab dly p.o 1tab dly po 1tab if required 1tab orally daily 1tab p.o daily 1tab p.o nocle 1tab p.o daily 1tab p.o nocte 1tab p.o three times 1tab po daily 1tab tds 1tab tds p.o 1tab tds p.o prn 1tab twice daily 1tabdly 1tablet daily orally 1tablet daily orally 1tablets daily orally 1tabs daily 1tabs dly 2 Tablets daily orally 2 ab daily orally 2 bd 2 daily 2 daily orally 2 dldy 2 dly 2 dly p.o. 2 drops twice 2 g immediately 2 g start p.o. 2 g stat orally 2 manne 3ncte 2 mg PRN 2 prn 2 puffs QiD 2 sachet 2 tab 2 tab 8hrly 2 tab Dly 2 tab QID po 2 tab b.d. 2 tab daily 2 tab daily orally 2 tab daly orally 2 tab dly 2 tab dly p-o 2 tab dly po 2 tab od po 2 tab po daily 2 tab po dily 2 tab po stat 2 tab prn 2 tab tds po 2 tab tds prn 2 tablet daily orally 2 tablets daily orally 2 tablets orally daily 2 tabs 2 tabs TDS p.o 2 tabs dly 2 tabs Dly 2 tabs P.R.N. 2 tabs bd 2 tabs daily 2 tabs daily orally 2 tabs daily oraly 2 tabs daily p-o 2 tabs dly 2 tabs dly p-o 2 tabs dly po 2 tabs orally 2 times 2 tabs orally when necessary 2 tabs p-o daily 2 tabs p-o tds 2 tabs p.o daily 2 tabs p.o. 2 tabs p.o. daily 2 tabs p.o.dly 2 tabs po 2 tabs prn 2 tabs start then 2 mg after each lose stool 2 tabs stat p.o 2 tabs tds 2 tabs tds p-o prn 2 tbs dly 2 tds po 200 mg 6hrly orally 200 mg 8 hourly 200 mg hrly orally 200 mg tds 200mg dly 200mg 3 times 200mg 8 hourly 200mg 8hrlly 200mg 8hrly orally 200mg TDS 200mg tds 200mg tds 3 times 200mg three times daily 200mg twice daily 20g Prn 24muimi 25 dly 25 mg p.o daily 25 mg p.o. daily 25 mg daily 25 mg daily orally 25 mg daily p.o. 25 mg dly 25 mg orally 25 mg p. daily 25 mg p.o daily 25 mg p.o daily 25 mg p.o. daily 25 mgb daily 250 mg imi d 250 mg imi start 250 mg imi stat 250 mg start dose 250mg imi 250mg imi start 250mg stat 25mg 25mg dly 25mg nocte 25mg p.o daily 25mg daily 25mg daily orally 25mg daily p-o 25mg dly 25mg dly p.o 25mg dly p.o 25mg mgnocte 25mg nocte 25mg oral at night 25mg p-o daily 25mg p.o daily 25mg po daily 2TAB DLY 1 TAB 2TABS DLY 2Tab Dly 2dly 2drops 12hourly 2g p.o .stat p.o. 2g sd 2g start 2g stat 2g stat dose 2g stat orally 2g stat p-o 2g stat po 2g stats orally 2mg stat 2mg after each loose stool 2mg after lose stool 2mg daily orally 2mg immediately 2mg p.o.daily 2mg prn 2mg when necessary 2prn 2satelets (1L daily) 2tab dly 2tab p.o daily 2tablet daily orally 2tablets daily orally 2tablets daily korally 2tablets daily orally 2tablets dly orally 2tablets stat orally 2tablets stat then 1 tablets after each loose stool 2tabs 2tabs daily 2tabs dly 2tabs dly p.o 2tabs 5hrly then 1 2tabs after loose stool 2tabs daily 2tabs daily orally 2tabs daily orally 2tabs daily po 2tabs dly 2tabs dly p.o 2tabs p.o daily 2tabs po daily 2tabs pon 2tabs prn 2tabs tds p.o 3 mg dly 30 mgdaily 300 g daily 300 m p.o . Daily 300 m p.o daily 300 mg daily 300 mg daily orally 300 mg daily p.o. 300 mg daiy orally 300 mg dly 300 mg nocte 300 mg p-o nocte 300 mg p.o daily 300 mg prn 300mg daily 300mg dly 300mg p.o daily 300mg 1/2 tab daily 300mg 1tab p-o daily 300mg daily 300mg daily orally 300mg daily p-o 300mg daly 300mg dly 300mg dly bd 300mg dly p.o 300mg dly po 300mg nocte 300mg p-o daily 300mg p-o nocte 300mg p.o daily 300mg p.o daily 300mg po daily 300ml 31/2 tab stats 01 4 drops 4 drops twice daily p-o 4 mg 8hourly orally 4 mg PRN ( bd ) 4 mg bd 4 mg prn 4 mg tds 4 mg three times daily 400 g po 3 times 400 g stat orally 400 mg 1 hourly 400 mg 6hrly orally 400 mg 8 hourlly 400 mg bd 400 mg p.o 400 mg p.o. prn 400 mg prn 400 mg shrtly orally 400 mg start 400 mg three times 400 mg/100 mg 12 hrly orally 400g p-o 8hrs 400g stat p-o 400mg p.o. stat p.o 400mg 8hrly p.o. 400mg bd 400mg p.o daily 400mg p.o prn 400mg stat 400mg stat dose 400mg 12,3mg po 400mg 6hrly 400mg 8 hrly 400mg bd 400mg dly 400mg hourly 400mg oral 6hourly 400mg oral 8hrly 400mg oral twice 400mg p-o stat 400mg p-o twice daily 400mg p.o prn 400mg sd 400mg single close 400mg start p.o. 400mg stat 400mg stat orally 400mg stat po 400mg tds /prn 400mg three times 450mg 2 tabs dly 480mg x2 daily 4gm bd 4mg tds/prn 4mg immidiately then 2mg prn 4mg 8hourly 4mg after each 4mg after each loose stool 4mg after each loose stools PRN 4mg bd 4mg bd po 4mg immediately then 2mg prn 4mg nocte 4mg prn 4mg twice 4mg,twice daily 4tabs bd po 5 mg daily 5 mg dly 5 mg orally 5 tab immidiately 50 mg stat orally 500 m 8 hourly orally 500 mg tds 500 g p.o.3 times 500 mg 500 mg p.o. three 500 mg 6 hrly 500 mg 6 hrly orally 500 mg 8 hrly 500 mg TDS 500 mg Tds 500 mg dly 500 mg orally 500 mg p.o. four times 500 mg po dly 500 mg start 500 mg start dose 500 mg stats 500 mg tds 500MG TDS 500g 8hrly 500g TDS 500g po twice 500g tds 500l 8hnrly orally 500m 500mg 500mg tds 500mg 12 hrl orally 500mg 3 times 500mg 3xdaily 500mg 6 hourly orally 500mg 6hrly 500mg 6hrly orally 500mg 6hrlyn orally 500mg 8 hrly 500mg 8hrly 500mg 8hrly orally 500mg 8wly orally 500mg TDS 500mg daily 500mg immediately 500mg immediately p.o 500mg oral stat 500mg oral twice 500mg p-o 500mg p-o 3times 500mg p-o four times 500mg p-o tds 500mg p-o twice Daily 500mg prn 500mg stat 500mg tbs 500mg tds 500mg tds p-o 500mg tds po 500mg tds prn 500mg three times daily orally 500mg twice 50g 8hrly orally 50mg dly 50mg dly 50mg tds 5m dly 5mg dly 5mg daily 5mg dly 5mg dly p.o 5mg oral daily 5mg po dly 5ml 8hrly orally 6 hourly 600 am 900 am nocte 600 mg bd 600g 8 hrly 600mg 12 hrly 600mg bd 600mg mane , 900mg 600mg mane 900mg 600mg mane 900mg nocte 600mg nocte 600mg p.o twice a day 600mg p.o twice a day 600mg, 900mg nocte 800mg 8 hourly 8hrly 900mg prn , 600mg 960 dly 960 mg o.d. 960 mg od 960 mg oral daily 960 mg po daily 960mg daily 960mg daily p-o 960mg daily p.o. 960mg daily po 960mg p.o daily 960mg p.o. daily 96mg daily Applicant Applied bd Applied twice daily Apply 1 dly Apply 3 times Apply Bd Apply cream daily Apply daily Apply daily orally Apply into eye tds Apply once daily affected area Apply once daily Apply topically Prn Apply twice day Apply twice topically I tab after each loose stool I tab daily I1 tab dly dly II drops twice II p.o. day II tabs daily II tabs dly p.o. II tabs p.o. start II tabs start then after loose stool II tabs tabs tds p.o prn II tabs tds p.o. prn II tds po Itab dly Noccte sd per vaginal Rub Rub at night Rub 3 times Rub at night Rub bd Wash twice daily applied bd apply at night apply bd apply + massage apply afafected area apply at night apply bd apply daily apply daily 1 tube apply dly apply nocte apply nocte once apply on skin apply once daily apply prn apply pv nocte apply tds apply twice apply twice daily appply bd appply twice insert 1 tab per vaginam insult at night intil 1-2 drops tds o/s per vaginal nocte pessory 500mg rub 3 times rub at night rub bd rub prn tab dly take 2tabs PRN after each loose stools to apply to apply twice a day vaginal cream nocte when necessary Period - days covered 1440 20 999 39.169 130.999 Individual identifier 125 272 27386 12500.056 8087.036 Cluster Type (arm) 124 Control Intervent Sex 125 FEM MAL Date of birth 125 1915-04-26 1998-06-24 Start date of secondline 125 2000-07-09 2015-05-28 Number of persons HIV Positive in same Household 85 40 2 3 4 5 Sysmiss Individual identifier 2394 272 27386 11981.761 7844.779 Cluster Type (arm) 2375 Control Intervent Sex 2394 FEM MAL Date of birth 2394 1915-04-26 1998-06-24 Start date of secondline 2394 2000-07-09 2015-05-28 Antiretroviral drug 1 2394 AZT NAD TDF Unknown d4T ddI Antiretroviral drug name 1 2394 Dideoxyinosine, Didanosine Missing (iDART) No drug Stavudine Tenofovir Zidovudine Antiretroviral drug 2 2394 3TC FTC NAD Unknown ddI Antiretroviral drug name 2 2394 Dideoxyinosine, Didanosine Emtricitabine Lamivudine Missing (iDART) No drug Antiretroviral drug 3 2394 ATVr EFV LPVr NVP RTV Unknown Antiretroviral drug name 3 2394 Atazanavir Efavirenz Lopinavir Missing (iDART) Nevirapine Ritonavir Antiretroviral drug 4 42 AZT TDF Antiretroviral drug name 4 42 Tenofovir Zidovudine Is regimen ATRIPLA? 2394 1 Date that regimen was started 2394 2000-03-15 2015-11-13 Date that regimen was stopped 66 2007-10-14 2015-08-16 Antiretroviral drug regimen 2394 AZT+3TC+EFV AZT+3TC+LPVr AZT+3TC+NVP AZT+FTC+EFV AZT+ddI+ATVr AZT+ddI+LPVr AZT+ddI+RTV NAD+NAD+LPVr TDF+3TC+ATVr TDF+3TC+EFV TDF+3TC+LPVr TDF+3TC+NVP TDF+FTC+EFV TDF+FTC+LPVr Unknown+Unknown+Unknown d4T+3TC+EFV d4T+3TC+LPVr d4T+3TC+NVP d4T+3TC+RTV d4T+FTC+EFV d4T+FTC+LPVr ddI+3TC+LPVr Individual identifier 136 585 26392 12812.36 7929.96 Cluster Type (arm) 135 Control Intervent Sex 136 FEM MAL Date of birth 136 1933-07-05 1996-06-18 Start date of secondline 136 2012-06-18 2015-04-16 SCI visit date 136 2012-07-04 2015-08-04 Adherence - ARV missed last week-end 136 Miss No Yes Adherence - Full daily dose in one go (last 4 days) 136 Miss No, Yes, CFU visit date 111 2012-11-06 2015-08-04 Adherence - Thinking back over the mast 4 days, have you missed any of your pills 111 Miss No Yes Adherence - Visual Analogue Scale (in %) 111 25 70 999 120.856 147.177 Adherence - Did the participant reurn the pill containers? 111 25 1 2 9 Sysmiss Adherence - Number of pills dispensed 111 25 32 999 410.486 381.473 Adherence - Number of pills returned 111 25 999 310.036 440.322 Adherence - Number of pills expected to be taken 111 25 25 999 394.712 391.095 Individual identifier 1393 272 27386 12059.093 7831.638 Cluster Type (arm) 1381 Control Intervent Sex 1393 FEM MAL Date of birth 1393 1915-04-26 1998-06-24 Start date of secondline 1393 2000-07-09 2015-05-28 Date of laboratory tests 1390 2005-01-05 2015-11-10 CD4 count from NHLS (/µL) 734 659 2 1497 296.896 220.796 ViralLoad: Viral Load (copies/mL) 1058 335 1 11000000 71708.195 454056.592 Individual identifier 125 272 27386 12594.608 7921.109 Cluster Type (arm) 124 Control Intervent Sex 125 FEM MAL Date of birth 125 1915-04-26 1998-06-24 Start date of secondline 125 2000-07-09 2015-05-28 Exit Type 38 Death Lost to Follow-Up No Mental Capacity Out Migration Transfer Out Death - Date of death generated from DTHVPDate 2 2014-07-09 2015-03-04 Death - Date of death as recorded (U means unknown) 4 20140101 201407UU 20150304 Death - Immediate cause 4 Sick natural cause sick wazikhunga Death - Underlying cause Lost to Follow-Up - Date of LFU generated from LFUVPDate Lost to Follow-Up - Date of LFU as recorded (U means unknown) 3 20131111 20141110 20151126 Lost to Follow-Up - Reason 3 Client exited because he residing at KwaMsane She missedvisits and she ran away from us the time we get her , she said she stopped taking tr over to the traditional medication she is taking . She went back to Qakwini clinic for collection of ARVs Transfer Out - Date of TFO generated from TROVPDate 15 2012-05-01 2015-03-14 Transfer Out - Date of TFO s recorded (U means unknown) 16 20120501 20121121 20130516 20130704 20130901 201401UU 20140206 20140416 20140901 20141105 20150126 201501UU 20150212 20150217 20150314 20150702 Transfer Out - Reason 16 He is working as security guard and allocated at Hluhluwe . He moved to Empangeni because he found job and he lived there. Kuthiwa usehlala ESikhawini , Ufika ngezimpelanyanga (Monthend ) Living at Mfekayi . Out migrated Gauteng Patient is now employed in Johannesburg , she has to locate as from today . Relocating to Mkhuze Sebakhe eMpangeni She is now staying eNkonjane working there use to be at home when if she is off after that back at w Usebenza eHluhluwe , uhlalela khona Usebenza eGoli Usebenza eHluhluwe ubuya monthend. Usehlala eNquthu usebenza khona ubuya ngamaholidi . Waya kumama wakhe useyohlala khona naye le KwaMduku ufunda Ongoye usebenza eGoli Out Migration - Date of OUT generated from OUTVPDate 9 2012-05-01 2015-03-14 Out Migration - Date of OUT as recorded (U means unknown) 23 20120501 201401UU 201403uu 20140901 20141105 20141120 20150126 201501UU 20150212 20150217 20150314 20150530 201505uu 20150608 20150620 201506UU 20150702 20150809 20150812 20150814 20150820 20151019 Out Migration - Reason 23 He moved to Empangeni because he found job and he lived there. Out migrated Gauteng Sebakhe eMpangeni Sehlala Empangeni She works in town and stay kwaMsane UseGoli ngokomsebenzi Usebenza eHluhluwe , uhlalela khona Usebenza eHluhluwe ubuya monthend. Usebenza eMakhakhathana ubuye month end Usebenza ngaseMthunzini uhlala khona ufika ngokuvakasha Usehlala eNquthu usebenza khona ubuya ngamaholidi . Usehlala kwaMsane. Usemsebenzini Embonambi lapho akathole khona itoho Usethole umsebenzi kwaMsane hlala khona. Uthi umama wakhe uhlala eDukuduku Waya kumama wakhe useyohlala khona naye le KwaMduku Work ufunda Ongoye usebenza eGoli usebenza empangeni usebenzela kwaMsane uthole itoho egoli kusho udadewabo nomawakhe uyobheka amatoho ethekwini Notes 9 Kusho umfowabo uMathaba , Mandlakhe . Relocated at KwaMsane. Sehlala eMpangeni usebenza khona . She is working at Empangeni The client stopped tr due to the traditional medication she is taking . The household member given the infromation of this participant working at Gauteng. Usebenza eHluhluwe ubuya monthend. Usehlala eGoli ngenxa yetoho . Washona last year ngo July